Androgen resurrection

Cohan, Gary R.
April 1998
Joe Weider's Muscle & Fitness;Apr98, Vol. 59 Issue 4, p138
States that people with aids die when their lean muscle mass approaches around 60 percent of the normal, according to findings of researchers in New York. Information on the use of testoterone-replacement therapy in persons with the human immunodeficiency firus (HIV); Indepth look at the changes undergone by HIV athlete, Bobbe Vagell; Views of Vagell. INSET: Training with HIV by Jeff O'Connell.


Related Articles

  • NIAID to test new AIDS vaccines on pregnant women with HIV. Doepel, Laurie K. // Public Health Reports;Jul/Aug93, Vol. 108 Issue 4, p526 

    Announces that the National Institute of Allergy and Infectious Diseases (NIAID) has begun the first clinical trials of therapeutic AIDS vaccine for pregnant women who are infected with HIV, but otherwise healthy. Hopes of stimulating antibody responses that will cross the placenta and protect...

  • HIV vaccine gets booster. Catalano, Peter // Insight on the News;02/17/97, Vol. 13 Issue 6, p42 

    Reports on the AIDS research community's new attitude toward developing and testing an AIDS vaccine. Allocation of funds for vaccine research; Retaining of HIV distinct pattern in the human lymphocytes; Prevention of HIV from attaching itself to immune cells through booster shots. INSET: AIDS...

  • Phase III Study Set to Evaluate Efficacy of Antiretroviral AIDS Vaccine. Guttman, Cheryl // Dermatology Times;Jun99, Vol. 20 Issue 6, p39 

    Reports on the launch of Phase III clinical trials in the United States to evaluate the efficacy of antiretroviral AIDS vaccines. Contributing factors to elusiveness of finding a cure; Goals; Fomivirsen sodium for cytomegalovirus retinitis; Famciclovir for treatment of zoster; Safety and...

  • Experts agree an AIDS vaccine is doable. Gallagher, John // Advocate;02/18/97, Issue 727, p35 

    Reports that experts in the United States agreed that the creation of a vaccination for AIDS was possible. Reasons experts were optimistic; Indepth look at the advances made with the treatment of AIDS; Comments from Julie McElrath, an associate professor of medicine at the University of...

  • Promising new research puts focus on AIDS vaccines. Portyansky, Elena // Drug Topics;7/20/98, Vol. 142 Issue 14, p22 

    Focuses on the developments highlighted at the International Biotechnology Conference and Exhibition in New York City, with reference to the acquired immune deficiency syndrome (AIDS) vaccines. Appearance of prevention with the surge of reports on various attempts to immunize organisms against...

  • ORAL HIV VACCINE TRIALS BEGIN.  // Advocate;6/28/94, Issue 658, p57 

    Reports on the start of oral HIV vaccine trials in the United States.

  • Scientists See Little Chance of AIDS Vaccine Soon. Harding, Rick // Advocate;10/13/87, Issue 483, p15 

    Reports on the prospects of finding an effective AIDS vaccine in the U.S. Clinical trials of an AIDS vaccine; Development of experimental AIDS vaccines; Concerns expressed about vaccine development.

  • Can We Make an AIDS Vaccine? Baltimore, David // National Forum;Summer99, Vol. 79 Issue 3, p35 

    Discusses the probability of developing a vaccine for AIDS. Why our immune system cannot control HIV; Details on how a vaccine could control HIV; Details on the study on the concept of how to induce the production of antibodies that would neutralize the virus.

  • The magic bullet. Wells, Ken R. // Advocate;11/28/95, Issue 695, p40 

    Looks at the lack of funds for the development of vaccines for the prevention of HIV infection. Decision of pharmaceuticals and private investors to divert funds to the development of therapeutic approaches for the disease; Profitability of a cure for AIDS instead of a means of prevention.

  • WHO/UNAIDS HIV vaccine initiative calls for accelerated research to build on trial accomplishments.  // Weekly Epidemiological Record;2/28/2003, Vol. 78 Issue 9, p62 

    Reveals that the World Health Organization/United Nations AIDS HIV vaccine initiative calls for accelerated research to build on trial accomplishments. Need for expansion of existing prevention efforts; Updates in companies developing AIDS/HIV vaccines.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics